Literature DB >> 21267007

A nonsense mutation in FMR1 causing fragile X syndrome.

Karen Grønskov1, Karen Brøndum-Nielsen, Alma Dedic, Helle Hjalgrim.   

Abstract

Fragile X syndrome is a common cause of inherited intellectual disability. It is caused by lack of the FMR1 gene product FMRP. The most frequent cause is the expansion of a CGG repeat located in the 5'UTR of FMR1. Alleles with 200 or more repeats become hypermethylated and transcriptionally silent. Only few patients with intragenic point mutations in FMR1 have been reported and, currently, routine analysis of patients referred for fragile X syndrome includes solely analysis for repeat expansion and methylation status. We identified a substitution in exon 2 of FMR1, c.80C>A, causing a nonsense mutation p.Ser27X, in a patient with classical clinical symptoms of fragile X syndrome. The mother who carried the mutation in heterozygous form presented with mild intellectual impairment. We conclude that further studies including western blot and DNA sequence analysis of the FMR1 gene should be performed in patients with typical symptoms of fragile X syndrome in whom no CGG repeat expansion is detected.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21267007      PMCID: PMC3060329          DOI: 10.1038/ejhg.2010.223

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  15 in total

1.  Mutational analysis of the FMR1 gene in 118 mentally retarded males suspected of fragile X syndrome: absence of prevalent mutations.

Authors:  K Grønskov; A Hallberg; K Brøndum-Nielsen
Journal:  Hum Genet       Date:  1998-04       Impact factor: 4.132

2.  Novel point mutation within intron 10 of FMR-1 gene causing fragile X syndrome.

Authors:  Y C Wang; M L Lin; S J Lin; Y C Li; S Y Li
Journal:  Hum Mutat       Date:  1997       Impact factor: 4.878

3.  Single-strand conformation polymorphism analysis in the FMR1 gene.

Authors:  S Castellví-Bel; A Sánchez; C Badenas; J Mallolas; A Barceló; D Jiménez; M Villa; X Estivill; M Milà
Journal:  Am J Med Genet       Date:  1999-05-28

4.  Deletion of all CGG repeats plus flanking sequences in FMR1 does not abolish gene expression.

Authors:  K Grønskov; H Hjalgrim; M O Bjerager; K Brøndum-Nielsen
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

5.  Identification of novel FMR1 variants by massively parallel sequencing in developmentally delayed males.

Authors:  Stephen C Collins; Steven M Bray; Joshua A Suhl; David J Cutler; Bradford Coffee; Michael E Zwick; Stephen T Warren
Journal:  Am J Med Genet A       Date:  2010-10       Impact factor: 2.802

6.  A point mutation in the FMR-1 gene associated with fragile X mental retardation.

Authors:  K De Boulle; A J Verkerk; E Reyniers; L Vits; J Hendrickx; B Van Roy; F Van den Bos; E de Graaff; B A Oostra; P J Willems
Journal:  Nat Genet       Date:  1993-01       Impact factor: 38.330

Review 7.  Severe mental retardation and macroorchidism without mutation in the FMR1 gene.

Authors:  E Reyniers; G Wolff; G Tariverdian; K De Boulle; K Storm; R F Kooy; P J Willems
Journal:  Am J Med Genet       Date:  1996-08-09

8.  Single-strand conformation polymorphism analysis of the FMR1 gene in autistic and mentally retarded children in Japan.

Authors:  Kumi Shinahara; Takahiko Saijo; Kenji Mori; Yasuhiro Kuroda
Journal:  J Med Invest       Date:  2004-02

9.  No apparent involvement of the FMR1 gene in five patients with phenotypic manifestations of the fragile X syndrome.

Authors:  P Chiurazzi; E de Graaff; J Ng; A J Verkerk; S Wolfson; G S Fisch; L Kozak; G Neri; B A Oostra
Journal:  Am J Med Genet       Date:  1994-07-15

10.  Intragenic loss of function mutations demonstrate the primary role of FMR1 in fragile X syndrome.

Authors:  K A Lugenbeel; A M Peier; N L Carson; A E Chudley; D L Nelson
Journal:  Nat Genet       Date:  1995-08       Impact factor: 38.330

View more
  19 in total

Review 1.  Fragile X-associated tremor/ataxia syndrome (FXTAS): pathology and mechanisms.

Authors:  Paul Hagerman
Journal:  Acta Neuropathol       Date:  2013-06-21       Impact factor: 17.088

Review 2.  Rare FMR1 gene mutations causing fragile X syndrome: A review.

Authors:  Adam F Sitzmann; Robert T Hagelstrom; Flora Tassone; Randi J Hagerman; Merlin G Butler
Journal:  Am J Med Genet A       Date:  2017-11-27       Impact factor: 2.802

3.  Fragile X syndrome due to a missense mutation.

Authors:  Leila K Myrick; Mika Nakamoto-Kinoshita; Noralane M Lindor; Salman Kirmani; Xiaodong Cheng; Stephen T Warren
Journal:  Eur J Hum Genet       Date:  2014-01-22       Impact factor: 4.246

4.  Most Martin-Bell syndrome (FMR1-related disorder) Venezuelan patients did not show CGG expansion but instead display genetic heterogeneity.

Authors:  Yasser Vega; Sergio Arias; Irene Paradisi
Journal:  J Hum Genet       Date:  2016-10-06       Impact factor: 3.172

5.  Intragenic FMR1 disease-causing variants: a significant mutational mechanism leading to Fragile-X syndrome.

Authors:  Angélique Quartier; Hélène Poquet; Brigitte Gilbert-Dussardier; Massimiliano Rossi; Anne-Sophie Casteleyn; Vincent des Portes; Claire Feger; Elsa Nourisson; Paul Kuentz; Claire Redin; Julien Thevenon; Anne-Laure Mosca-Boidron; Patrick Callier; Jean Muller; Gaetan Lesca; Frédéric Huet; Véronique Geoffroy; Salima El Chehadeh; Matthieu Jung; Benoit Trojak; Stéphanie Le Gras; Daphné Lehalle; Bernard Jost; Stéphanie Maury; Alice Masurel; Patrick Edery; Christel Thauvin-Robinet; Bénédicte Gérard; Jean-Louis Mandel; Laurence Faivre; Amélie Piton
Journal:  Eur J Hum Genet       Date:  2017-02-08       Impact factor: 4.246

6.  C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD.

Authors:  Elaine Y Liu; Jenny Russ; Kathryn Wu; Donald Neal; Eunran Suh; Anna G McNally; David J Irwin; Vivianna M Van Deerlin; Edward B Lee
Journal:  Acta Neuropathol       Date:  2014-05-08       Impact factor: 17.088

Review 7.  The unstable repeats--three evolving faces of neurological disease.

Authors:  David L Nelson; Harry T Orr; Stephen T Warren
Journal:  Neuron       Date:  2013-03-06       Impact factor: 17.173

Review 8.  Pharmacological and Therapeutic Approaches in the Treatment of Epilepsy.

Authors:  Shampa Ghosh; Jitendra Kumar Sinha; Tarab Khan; Kuramkote Shivanna Devaraju; Prabhakar Singh; Kumar Vaibhav; Pankaj Gaur
Journal:  Biomedicines       Date:  2021-04-25

9.  A quantitative homogeneous assay for fragile X mental retardation 1 protein.

Authors:  Gabi Schutzius; Dorothee Bleckmann; Sandra Kapps-Fouthier; Francesco di Giorgio; Bernd Gerhartz; Andreas Weiss
Journal:  J Neurodev Disord       Date:  2013-04-02       Impact factor: 4.025

10.  A novel fragile X syndrome mutation reveals a conserved role for the carboxy-terminus in FMRP localization and function.

Authors:  Zeynep Okray; Celine E F de Esch; Hilde Van Esch; Koen Devriendt; Annelies Claeys; Jiekun Yan; Jelle Verbeeck; Guy Froyen; Rob Willemsen; Femke M S de Vrij; Bassem A Hassan
Journal:  EMBO Mol Med       Date:  2015-04       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.